Literature DB >> 5804375

Differentiation of malignant from benign lesions of the thyroid gland using complementary scanning with 75Selenomethionine and radioiodide.

C G Thomas, F D Pepper, J Owen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5804375      PMCID： PMC1387686          DOI： 10.1097/00000658-196909010-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  13 in total

1.  THE USE OF IODINE 125 IN THYROID SCINTISCANNING.

Authors:  N D CHARKES; D M SKLAROFF
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1963-11

2.  Scintillation scanning in the management of the clinically single thyroid nodule.

Authors:  P M MEADOWS
Journal:  JAMA       Date:  1961-07-29       Impact factor: 56.272

3.  Gross and microscopic findings in clinically normal thyroid glands.

Authors:  J D MORTENSEN; L B WOOLNER; W A BENNETT
Journal:  J Clin Endocrinol Metab       Date:  1955-10       Impact factor: 5.958

4.  The thyroid scintigram. II. The cold nodule.

Authors:  J M Miller; J I Hamburger; R C Mellinger
Journal:  Radiology       Date:  1965-10       Impact factor: 11.105

5.  Role of scintillation scanning in clinical medicine. II.

Authors:  L M Freeman; J A Schneider; C J Kay; L H Zingesser; C Zimmerman
Journal:  N Y State J Med       Date:  1966-08-15

6.  Se75-selenomethionine incorporation into human plasma proteins and erythrocytes.

Authors:  H K Qawwad; E J Potchen; S J Adelstein; J B Dealy
Journal:  Metabolism       Date:  1966-07       Impact factor: 8.694

7.  The thyroid uptake of selenium-75-selenomethionine: effect of L-thyroxine and thyroid stimulating hormone.

Authors:  E J Potchen; H K Awwad; S J Adelstein; J B Dealy
Journal:  J Nucl Med       Date:  1966-06       Impact factor: 10.057

8.  Se methionine as a diagnostic agent in malignant lymphoma.

Authors:  N E Herrera; R Gonzalez; R D Schwartz; A M Diggs; J Belsky
Journal:  J Nucl Med       Date:  1965-11       Impact factor: 10.057

9.  The regional distribution of Se75-selenomethionine in the rat.

Authors:  H K Awwad; E J Potchen; S J Adelstein; J B Dealy
Journal:  Metabolism       Date:  1966-04       Impact factor: 8.694

10.  Radioisotope scanning of the thyroid.

Authors:  J L Quinn; M Behinfar
Journal:  JAMA       Date:  1967-03-20       Impact factor: 56.272
View more
  11 in total

1.  Secondary lymphoma of the thyroid in 99mTc-pertechnetate scintigraphy.

Authors:  W J Shih; M L Cibull; R A Wahbrink; P A Domstad
Journal:  Eur J Nucl Med       Date:  1987

2.  Application of special diagnostic techniques in the management of nodular goitre.

Authors:  P G Walfish; M Miskin; I B Rosen; H T Strawbridge
Journal:  Can Med Assoc J       Date:  1976-07-03       Impact factor: 8.262

3.  Diagnostic value of early and delayed 201Tl thyroid scintigraphy in the evaluation of cold nodules for malignancy.

Authors:  E Henze; J Roth; H Boerer; W E Adam
Journal:  Eur J Nucl Med       Date:  1986

4.  Poorly differentiated neoplasms of the thyroid gland.

Authors:  C G Thomas; J A Buckwalter
Journal:  Ann Surg       Date:  1973-05       Impact factor: 12.969

5.  Solitary thyroid nodule.

Authors:  H Wade
Journal:  Ann R Coll Surg Engl       Date:  1974-07       Impact factor: 1.891

6.  Editorial: Diagnosis of thyroid diseases.

Authors:  R Volpé
Journal:  Can Med Assoc J       Date:  1974-05-04       Impact factor: 8.262

7.  Clinical evaluation of 201thallium chloride scan for thyroid nodule.

Authors:  T Harada; Y Ito; K Shimaoka; T Taniguchi; A Matsudo; T Senoo
Journal:  Eur J Nucl Med       Date:  1980-04

8.  Clinical aspects of thyroid cancer.

Authors:  I B Rosen
Journal:  Can Med Assoc J       Date:  1969-11-29       Impact factor: 8.262

9.  Evaluation of dominant thyroid masses.

Authors:  C G Thomas; J A Buckwalter; E V Staab; C Y Kerr
Journal:  Ann Surg       Date:  1976-05       Impact factor: 12.969

Review 10.  Thyroid nodules and thyroid cancer.

Authors:  F S Greenspan
Journal:  West J Med       Date:  1974-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.